Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

SELL
$1.14 - $1.81 $20,665 - $32,811
-18,128 Reduced 99.97%
6 $0
Q2 2023

Aug 07, 2023

BUY
$1.79 - $4.59 $17,565 - $45,041
9,813 Added 117.93%
18,134 $32,000
Q1 2023

May 08, 2023

SELL
$2.84 - $3.92 $10,499 - $14,492
-3,697 Reduced 30.76%
8,321 $32,000
Q4 2022

Feb 01, 2023

BUY
$2.48 - $5.93 $4,037 - $9,654
1,628 Added 15.67%
12,018 $40,000
Q2 2022

Aug 09, 2022

SELL
$4.15 - $8.37 $1,041 - $2,100
-251 Reduced 2.36%
10,390 $47,000
Q1 2022

Apr 21, 2022

BUY
$5.91 - $14.38 $27,564 - $67,068
4,664 Added 78.03%
10,641 $78,000
Q1 2020

May 06, 2020

BUY
$14.38 - $27.72 $30,039 - $57,907
2,089 Added 53.73%
5,977 $115,000
Q2 2018

Aug 06, 2018

BUY
$12.0 - $19.88 $46,656 - $77,293
3,888 New
3,888 $66,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $49.5M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.